EUKARYOTIC CELL, Nov. 2008, p. 1880â€“1887                                                                                        Vol. 7,  11
1535-9778/08/$08.00â«¹0 doi:10.1128/EC.00222-08
Copyright Â© 2008, American Society Microbiology. Rights Reserved.



        Synthetic Genetic Network PKC1 Identifies Novel
         Modulators Components Protein Kinase C Signaling                          Saccharomyces cerevisiaeäŒ¤
                                   Sue  Krause,1 Hong Xu,2â€  Joseph V. Gray1*
      Molecular Genetics Integrative & Systems Biology, Faculty Biomedical Life Sciences, University Glasgow,
           Anderson College Complex, 56 Dumbarton Road, Glasgow G11 6NU, United Kingdom,1 Banting                    Best Department Medical Research, University Toronto, 112 College Street, Toronto,
                                                 Ontario M5G 1L6, Canada2
                                             Received 7 July 2008/Accepted 9 September 2008

             Budding yeast Saccharomyces cerevisiae contains protein kinase C (PKC) isozyme encoded           essential gene PKC1. Pkc1 activated small GTPase Rho1 plays central role cell wall
          integrity (CWI) signaling pathway. pathway acts primarily remodel cell surface           normal life cycle various environmental stresses. pathway heavily branched, multiple
          nonessential branches feeding central essential Rho1-Pkc1 module. attempt identify
          novel components modifiers CWI signaling, determined synthetic lethal genetic network           PKC1 using dominant-negative synthetic genetic array analysis. resulting mutants hypersensitive           lowered Pkc1 activity. corresponding 21 nonessential genes closely related CWI function: 14 behave
          chemical-genetic epistasis test acting pathway, 6 genes encode known components.
          21 null mutants display elevated CWI reporter activity, consistent idea pathway
          activated compensates loss gene products. 21 mutants display low CWI reporter
          activity, consistent idea pathway compromised mutants. group
          mutants lacks Ack1(Ydl203c), uncharacterized SEL-1 domain-containing protein modulates
          pathway activity. Epistasis analysis places Ack1 upstream Pkc1 CWI pathway dependent           upstream Rho1 GTP exchange factors Rom2 Tus1. Overall, synthetic genetic network PKC1
          directly efficiently identifies known novel components PKC signaling yeast.


   cell wall integrity (CWI) pathway acts primarily main-             perturbations, detected effect cell surface
tain cell integrity life cycle (reviewed refer-            sensed multiple members WSC family cell
ence 22). pathway responds variety external                 surface sensors (11, 15, 38). putative mechano-sensors internal stresses, heat shock, hypo-osmotic shock,               bind activate Rho guanine nucleotide exchange
cytoskeletal defects, cell wall defects, secretion blocks.           factors (GEFs) Rom2 Tus1 activate Rho1 (28, 32).
pathway acts regulate activity expression key cell wall             upstream signaling complex, mul-
synthesis enzymes control processes actin po-                 tiple additional branches feeding information path-
larization polarized secretion ensure appropriate                  way. signals transduced Rho1 regulators modeling cell surface.                                                independently WSC sensors, e.g., TOR signaling mod-
   small GTPase Rho1 central CWI pathway.                      ulates Rho1 GEF Rom2 (33), CDK1/Cdc28 directly phos-
Rho1-GTP directly binds activates multiple effectors,                 phorylates Rho1 GEF Tus1 (19), mRNA binding
including Fks1/2 glucan synthases, Bni1/Bnr1 formins,                protein Mpt5 inhibits expression Rho1 GTPase-activat- exocyst component Sec3 (22). key direct                      ing protein Lrg1 (34). Finally, actin cytoskeletal defects appear
target Pkc1, Saccharomyces cerevisiae homolog                 sensed unknown mechanism independent mammalian protein kinase C essential protein required                 WSC sensors known Rho1 regulators (12). maintenance cell integrity (21).                                      focus Pkc1 hub CWI pathway. Pkc1
   CWI pathway stimulated variety intrinsic               controls multiple downstream branches, best understood extrinsic signals transduced variety upstream branches              mitogen-activated protein (MAP) kinase cascade
(22). signals, e.g., heat shock cell wall                  terminating Slt2 MAP kinase. cascade essen-
                                                                             tial normal conditions required cells survive
                                                                             stresses high temperature. Slt2 known directly
   * Corresponding author. Mailing address: Molecular Genetics Integrative & Systems Biology, Faculty Biomedical Life Sci-
                                                                             activate,  Rlm1 Swi4 transcription fac-
ences, University Glasgow, Anderson College Complex, 54-56                tors, important expression genes involved Dumbarton Road, Glasgow G11 6NU, United Kingdom. Phone: (141)                cell surface construction (1, 41).
330-6135. Fax: (141) 330-4878. E-mail: J.Gray@bio.gla.ac.uk.                    set identify new regulators components    â€  Present address: Molecular Oncology Breast Cancer Program,
BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, Brit-
                                                                             CWI/Pkc1 pathway. chose genetic strategy. Synthetic
ish Columbia V5Z 1L3, Canada.                                                lethal genetic interactions, type phenotype enhancement,
   äŒ¤
     Published ahead print 19 September 2008.                          occur loss function mutations different genes

                                                                      1880
 VOL. 7, 2008                                                                                            GENETIC NETWORK PKC1                               1881


cause lethality present  interac-                       2â?®PKC1 (DL289) plasmids (40); pROM2-HA pSLT2-HA (33); pROM2-GFP
tions systematically uncovered yeast                          pTUS1-GFP (44); pMKK1 (14).
                                                                                       pACK1 pTUS1 generated inserting respective genes given â€œqueryâ€? mutation using synthetic genetic array (SGA)                       vector, pGREG535 (Euroscarf), homologous recombination. vector 
analysis (36) diploid-based synthetic lethality analysis                    tains GAL1,10 promoter hemagglutinin tag. vector digested microarrays (27). synthetic genetic interactions tend                      SalI remove  marker. PCR amplified genes (using Ack1F Ack1R occur genes parallel â€œbufferingâ€? pathways                          Tus1F Tus1R) cotransformed SalI-digested pGREG535                                                                                     BY4741 yeast cells. Transformants selected SD-Leu plates. Plasmid
processes, mutations essential genes thought prefer-                      DNA independent yeast colonies transformed XL1-Blue
entially sensitize organism second mutation affects                    Escherichia coli cells (Stratagene). Plasmid DNA purified, presence parallel process (26).                                       orientation insert confirmed restriction digestion. function
    determined set mutations nonessential                         plasmids confirmed vivo complementation relevant
                                                                                    null-mutant phenotypes.
genes (null mutations) confer hypersensitivity lowered
                                                                                       DN-SGA analysis. DN-SGA analysis performed previously described
Pkc1 activity novel modification SGA analysis, domi-                       SGA analysis (36, 37), following modifications. chromo-
nant-negative SGA (DN-SGA) analysis.                           somal copy PKC1 left unaltered query strain (Y4115). Instead, corresponding 21 genes closely functionally linked                      wild-type â€œqueryâ€? strain transformed URA3-marked plasmid [pGAL-
                                                                                    PKC1(dead)] expressing dominant-negative allele PKC1 encoding catalyt- CWI pathway, including uncharacterized YDL203c/
                                                                                    ically inactive length protein [Pkc1(dead)] expressed control ACK1 gene, encodes new upstream modulator basal                          inducible GAL1,10 promoter. transformed query strain crossed CWI activity.                                                                       arrayed haploid deletion collection (â¬ƒ4,700 viable null mutants) glucose-
                                                                                    containing medium lacking uracil. Subsequent sporulation selection                                                                                     transformed haploid progeny yielded arrayed collection haploid deletion
                        MATERIALS METHODS                                       mutants, containing pGAL-PKC1(dead). arrayed collection sub-
                                                                                    sequently pinned SGalactose-URA medium, transformants prolifer-
   Media, chemicals, transformation. rich yeast medium (YPD)            ated poorly,  1 day inducing medium identified. sisted 1  Bacto yeast extract (Difco), 2  peptone (Difco), 2  glucose.       analysis repeated twice, mutants grew poorly,  Rich YPGalactose medium described YPD, 2  galactose          induction Pkc1(dead) independent runs sole carbon source. Synthetic derived medium (SD, SGal, Suc, SRaffinose)     considered positives.
contained 0.67  yeast nitrogen base amino acids (Difco); 2  glucose,           Determination staurosporine sensitivity. sensitivity strain 2  galactose, 0.005  sucrose, 2  raffinose, respectively; appropriate        Pkc1 inhibitor staurosporine determined follows. Cells cultured
nutrient supplements drug additions appropriate. Solid media      overnight YPD (untransformed cells) room temperature supplemented
described  addition 2  Bacto agar (Difco). Chemicals         sorbitol (1 M) appropriate. Cultures diluted fresh medium Sigma-Aldrich unless stated  Restriction enzymes New       incubated agitation 6 h room temperature. Culture density England Biolabs. transformations performed using conventional          adjusted optical density 600 nm (OD600) 0.05. Aliquots (100 â?®l) lithium acetate method (10).                                                        placed wells sterile 96 microtiter plate, staurosporine     Oligonucleotides. following primers used (Sigma-Aldrich): Ack1F         vehicle control) added. plates incubated room
(5â¬˜-GAATTCGATATCAAGCTTATCGATACCGTCGACAATGGTTAATC                                    temperature overnight gentle agitation. final OD600 culture AGGGCCAACC-3â¬˜), Ack1R (5â¬˜-GCGTAGCATAACTAATTACATGACTCG                               determined using plate reader. analysis performed times.
AGGTCGACTTAATTTGTCAAACTTCGAAGAGC-3â¬˜), Tus1F (5â¬˜-GAATT                                  Determination sensitivity tunicamycin, calcofluor white, chlorpromazine,
CGATATCAAGCTTATCGATACCGACAATGTATCGATATAATTAGAA                                      benomyl. Mutants congenic wild-type cells grown YPD GTTCCCCT-3â¬˜), Tus1R (5â¬˜-GCGTAGCATAACTAATTACATGACTCG                             synthetic medium mid-logarithmic phase. cultures diluted AGGTCGACTTATTGATGATCTGCCATTGCT-3â¬˜). identities                          OD600 0.02, serial dilutions fresh medium  Samples (5 â?®l)
haploid deletion strains confirmed PCR amplification replacement     dilution spotted fresh plates tunicamycin (1.5
locus, using KanB primer appropriate gene-specific â€œPrimer ?           â?®g/ml), calcofluor white (150 â?®g/ml), chlorpromazine (200 â?®g/ml) (Calbiochem),
flanking primer according Yeast Knockout Consortium (http://www              benomyl (20 â?®g/ml). plates incubated 2 3 days 25Â°C.
-sequence.stanford.edu/group/yeast_deletion_project/confirmation.html).                Quantifying Rlm1-dependent reporter activity. Cells transformed    Strains, genetic crosses, plasmids. S. cerevisiae strains used   LacZ reporter construct, pRLM1-LacZ (17). Transformed cells cultured derived BY4741 BY4742 yeast strain S288c strain         mid-logarithmic phase SD-URA room temperature, â?¤-galactosidase
ground. DN-SGA screen, query strain MATâ?£ Mfa1âŒ¬::MFA1pr-             activity quantified Miller Units standard protocol according HIS3 can1âŒ¬ his3âŒ¬ leu2âŒ¬ ura3âŒ¬ MET15â«¹ lys2âŒ¬ transformed pGAL1-                   Stewart et al. (34). estimation stress induction CWI signaling,
PKC1(dead). obtained wild-type BY4741 strain, genotype              transformed cells treated calcofluor white (150 â?®g/ml), chlorproma-
MATa his3âŒ¬1 leu2âŒ¬ met15âŒ¬ ura3âŒ¬ (Euroscarf), derivative single        zine (200 â?®g/ml), latruculin B (40 â?®g/ml) 3 h 25Â°C prior null mutations api2âŒ¬::KanMX4, atg15âŒ¬::KanMX4, bck1âŒ¬::KanMX4, bni1âŒ¬::                â?¤-galactosidase assay. assays performed triplicate separate
KanMX4, chl1âŒ¬::KanMX4, cik1âŒ¬::KanMX4, csf1âŒ¬::KanMX4, ctf19âŒ¬::KanMX4,                days. relative reporter activity mutant calculated relative egd1âŒ¬::KanMX4, jnm1âŒ¬::KanMX4, las21âŒ¬::KanMX4, mid1âŒ¬::KanMX4, mig1âŒ¬::                level untreated congenic wild-type cells assayed day.
KanMX4, opi3âŒ¬::KanMX4, ost3âŒ¬::KanMX4, per1âŒ¬::KanMX4, rom2âŒ¬::KanMX4,
sec28âŒ¬::KanMX4, spa2âŒ¬::KanMX4, swi4âŒ¬::KanMX4, tus1âŒ¬::KanMX4, ump1âŒ¬::
KanMX4, ydl203câŒ¬::KanMX4. obtained wild-type strain                                                   RESULTS
BY4742, genotype MATâ?£ his3âŒ¬1 leu2âŒ¬ lys2âŒ¬ ura3âŒ¬, homozy-
gous wsc1âŒ¬/âŒ¬ diploid mutant MATa/MATâ?£ his3âŒ¬1/his3âŒ¬1 leu2âŒ¬/leu2âŒ¬ met15âŒ¬/                previously shown allele PKC1 encoding MET15 LYS2/lys2âŒ¬ ura3âŒ¬/ura3âŒ¬ wsc1âŒ¬::KanMX4/wsc1âŒ¬::KanMX4                catalytically inactive length protein behaves dominant-
strain background (Euroscarf). deletion, marked NatMX, TUS1           negative allele (40), e., expression allele trans lowers
gene generated query strain described Tong et al. (36). temperature-sensitive mutant PKC1, stt1-1, W303 strain 
                                                                                    Pkc1 activity presence wild-type chromosomal
ground (MATa ura3âŒ¬ leu2âŒ¬ trp1âŒ¬ his3âŒ¬ ade2âŒ¬ can1-100) (43). homozygous           copy gene (11). exploited allele identify slt2âŒ¬/âŒ¬ strain EG123 strain background (MATa/MATâ?£ trp1âŒ¬/trp1âŒ¬            synthetic genetic network PKC1.
leu2âŒ¬/leu2âŒ¬ ura3âŒ¬/ura3âŒ¬ his4âŒ¬/his4âŒ¬ can1âŒ¬/can1âŒ¬) (11).                                 DN-SGA analysis. transformed wild-type query
   genetic backcrosses congenic wild-type cells opposite    strain marked plasmid expressing catalytically inac-
mating type. Haploid rom2âŒ¬ tus1âŒ¬ cells generated standard genetic
manipulations cross tus1::NatMX4 rom2::KanMX4 haploid
                                                                                    tive allele PKC1 [pkc1(dead)] control ga-
strains.                                                                            lactose-inducible GAL1,10 promoter (40). transformed
   plasmids used study include pGAL-PKC1, pGAL-PKC1(dead),          query strain crossed arrayed haploid deletion
 1882      KRAUSE ET AL.                                                                                                             EUKARYOT. CELL


                                                                           sensitivity cosegregated marked deletion 10
                                                                           tetrads 21 28 cases genetic backcrosses, consistent
                                                                           idea mutations cause sensitivity lowered
                                                                           Pkc1 activity. identity knockout strain                                                                            successfully confirmed PCR. 21 mutants constitute
                                                                           PKC1 interaction network (Table 1).
                                                                              Chemical sensitivity links interacting genes CWI
                                                                           pathway. Pkc1-Slt2 activity stimulated multiple different
                                                                           stresses cell. stresses caused                                                                            chemical treatment: chlorpromazine deforms plasma mem-
                                                                           brane (5), calcofluor white disrupts chitin structure cell
                                                                           wall (29), tunicamycin indirectly causes secretion block
   FIG. 1. Chemical-genetic analysis indicates thirds      interfering protein glycosylation (20). Mutants defec-
PKC1 genetic interaction network comprises  pathwayâ€? inter-         tive Pkc1 pathway closely allied processes tend actions.   Example sorbitol suppression hypersensitivity    hypersensitive compounds. null mutant staurosporine. Wild-type api2âŒ¬ cells grown
                                                                           21 mutants PKC1 network rich medium diluted wells 96 plate containing
fresh medium supplemented staurosporine (range, 0 â?®g/ml 50         sensitive chemicals, 12 (57 ) sen-
â?®g/ml). cells incubated presence (â«¹)      sitive  6 (29 ) sensitive absence (â«º) sorbitol (1 M). (B) Scheme illustrating functional      (Table 2). conclude mutants PKC1-
classification PKC1-interacting genes. Fourteen genes        interacting network display phenotypes associated
behave encoding proteins act Pkc1 pathway (staurospor-
ine sensitivity suppressed osmotic stabilization),      CWI dysfunction.
encode known CWI pathway components  text). remaining                 PKC1 network rich known components. expect
seven genes behave encoding proteins function,    PKC1-interacting genes encode components parallel Pkc1 (staurosporine sensitivity suppressed osmotic   branched CWI pathway (26).  6 stabilization).
                                                                           21 interacting genes (29 ) encode known components                                                                            Pkc1 pathway (Table 1) (22): Bck1, direct target                                                                            kinase; Swi4 Mig1 downstream transcription factors;
collection, resulting arrayed, transformed haploid mutant               Bni1 formin Mid1 calcium channel, act
progeny generated standard SGA methodology (36). â¬ƒ5,000 arrayed transformants transferred 
dium containing galactose sole carbon source (inducing
                                                                                     TABLE 1. Confirmed genes members condition), growth spot noted.                                                                                                      PKC1 network transformants grew poorly galac-
                                                                             Genea                        Protein function processb
tose-containing medium independent
runs taken constitute set primary mutants iden-             API2 ............Protein unknown function.
tified analysis.                                                    ATG15 ........Lipase required intravacuolar lysis                                                                                               autophagosomes.
   Mutants eliminated analysis                                                                            BCK1 ...........MAP kinase kinase downstream Pkc1. following applied:   untransformed mutants                  BNI1............Formin nucleates formation linear actin
unable proliferate galactose sole carbon source,                                 filaments. eliminating gal mutants; (ii) sensitivity expression         CHL1 ..........Protein required establishing sister chromatid
Pkc1(dead) reproduced direct transformation;                                  pairing S phase.
                                                                           CIK1............Kinesin-associated protein required karyogamy (iii) mutants sensitive expression wild-type Pkc1                                  mitotic spindle orientation.
driven equivalent pGAL-PKC1(WT) construct,                 CSF1 ...........Protein required low-temp fermentation.
eliminating sensitive overexpression protein               CTF19 .........Outer kinetochore protein required mitotic lowered activity.  29 mutants survived                              chromosome segregation.
                                                                           EGD1..........Protein involved novo cotranslational protein
triage behaved reproducibly sensitive induc-
                                                                                              folding.
tion Pkc1(dead) expression.                                             JNM1.......... dynactin complex required proper nuclear
   Confirmation genetic interactions: staurosporine sensi-                                 migration spindle partitioning.
tivity. wished independently confirm genetic inter-              LAS21 .........Protein involved synthesis GPI anchors.
actions PKC1. Staurosporine broad-spectrum protein               MID1...........Calcium channel.
                                                                           MIG1...........Transcription factor involved glucose repression.
kinase inhibitor preferentially inhibits isozymes protein          OPI3............Phospholipid methyltransferase.
kinase C (35). Pkc1 appears limiting target stau-             OST3 ...........Subunit oligosaccharyltransferase ER lumen.
rosporine yeast (40, 43).  sensitivity wild-type          PER1 ...........Protein required GPI-phospholipase A2 activity.
cells staurosporine, like inviability pkc1âŒ¬ mutants,          SEC28 .........Protein required ER-Golgi retrograde transport.
                                                                           SPA2............Component polarisome acts scaffold Mkk1
suppressed osmotic stabilization (Fig. 1A data                                                                                               Slt2.
shown). Furthermore, pretreatment staurosporine abol-                 SWI4............Transcription factor involved late G1 gene expression.
ishes activation CWI signaling challenge stress               UMP1..........Chaperone required maturation 20S proteasome.
(S.  Krause J. V. Gray, unpublished observation).                 YDL203c ....Protein unknown function. 28 29 robust mutants identified DN-SGA                                                                                                   Genes encoding known components CWI pathway bold.
analysis hypersensitive staurosporine. hyper-               b
                                                                                 GPI, glycosylphosphatidylinositol; ER, endoplasmic reticulum.
 VOL. 7, 2008                                                                                         GENETIC NETWORK PKC1                        1883


   TABLE 2. Chemical sensitivities null mutants PKC1                        majority interacting genes encode inhibitors CWI
                    interaction network                                            signaling. functional relationships link interacting
                                     Level sensitivitya                      gene products Pkc1 function? gene products Mutant                                                                             function inhibitors CWI signaling. Mutants lacking                                           Calcofluor
                   Tunicamycin                                   Chlorpromazine    proteins defective processes CWI
                                            white
                                                                                   pathway responds, e.g., cell wall construction, result-
atg15                   â«¹                     â«¹                        â«¹
chl1                    â«¹                     â«¹                        â«¹           ing elevation pathway activity acting ameliorate 
cik1                    â«¹                     â«¹                        â«¹           sequences mutations.
csf1                    â«¹                     â«¹                        â«¹              estimated CWI pathway activity 21 null mutants
ctf19                   â«¹                     â«¹                        â«¹           using established transcriptional reporter ex-
egd1                    â«¹                     â«¹                        â«¹
bck1                    â«¹                     â«¹                        â«º
                                                                                   pression bacterial LacZ gene dependent Rlm1
jnm1                    â«¹                     â«¹                        â«º           transcription factor (17). reporter faithfully reflects las21                   â«¹                     â«¹                        â«º           activity state Pkc1-MAP kinase pathway (17). ost3                    â«¹                     â«¹                        â«º           majority mutants (12/21) display high basal Rlm1-
sec28                   â«¹                     â«¹                        â«º
                                                                                   LacZ reporter activity (Fig. 2). mutants highest
opi3                    â«¹                     â«º                        â«¹
mid1                    â«¹                     â«º                        â«º           basal reporter activity (â¬Ž3 times wild-type cells) point
per1                    â«¹                     â«º                        â«º           best-known triggers roles CWI signaling:
spa2                    â«¹                     â«º                        â«º           las21âŒ¬, per1âŒ¬, ost3âŒ¬ defective cell wall/surface syn-
ump1                    â«¹                     â«º                        â«º           thesis (2, 7, 18), bni1âŒ¬  api2âŒ¬ thought 
ydl203c                 â«¹                     â«º                        â«º
api2                    â«º                     â«¹                        â«º           defective actin organization/cell morphogenesis (3, 6). bni1                    â«º                     â«¹                        â«º           novel trigger suggested high reporter activity seen swi4                    â«º                     â«¹                        â«º           opi3âŒ¬ mutants. mutant lacks phospholipid methyltrans-
mig1                    â«º                     â«º                        â«¹           ferase required phosphatidylcholine (PC) synthesis (23).
      â«¹ indicates hypersensitivity compound relative sensitivity    CWI pathway respond changes PC
congenic wild-type control cells. â«º indicates sensitivity indistinguishable   levels, complementing established role Pkc1 directly congenic wild-type cells.
                                                                                   phosphorylating enzymes involved PC synthesis (4, 42).
                                                                                      date, feedback control CWI signaling estab-
                                                                                   lished MAP kinase downstream branch (22). Impor-
                                                                                   tantly, mutants PKC1 network displaying distinct downstream branches; Spa2, component                          elevated Rlm1-LacZ reporter activity lack known component polarisome complex  Bni1, properly localizes                     pathway.  Swi4, acts downstream downstream MAP kinase module cell periphery.                                MAP kinase branch:  Bni1 Mig1, (22).
   Chemical-genetic epistasis test. 15 genes                         observations support feedback control CWI path-
closely linked CWI signaling? begin address ques-
tion, exploited unique property pkc1âŒ¬ mutants: invia-
bility suppressed high-osmolarity medium, condition thought physically stabilize fragile mutant cells
(22). Pathway activity required cell viability condition. High osmolarity does completely
bypass requirement kinase: Pkc1 required growth high temperature, condition.
   reasoned mutations affect Pkc1 pathway/
process enhance phenotype caused loss Pkc1 activity osmotically stabilized medium room
temperature. Pathway activity required 
dition,  mutations affecting pathway com-
ponent exacerbate phenotypes mutants lowered Pkc1 activity. Osmotic stabilization suppress synthetic genetic interaction PKC1
noted normal media. contrast, mutations affect                          FIG. 2. basal activity Rlm1-LacZ reporter construct parallel process enhance pkc1 defects ab-                       altered majority Pkc1 genetic network. 21
sence presence osmotic stabilization, previ-                     network mutants, congenic wild-type strain, trans-
ously noted BRO1 gene (25).                                           formed plasmid containing LacZ expressed control                                                                                    Slt2-dependent transcription factor Rlm1. transformed mu-
   tested 21 mutants. 1 M sorbitol sup-                       tants assayed â?¤-galactosidase activity. relative activity presses staurosporine hypersensitivity thirds                    determined comparison activity wild-type transformed
mutants (Fig. 1A B), functionally linking cor-                     cells. experiment performed multiple different days responding gene products Pkc1. chemical-genetic test                       triplicate day. Data day scaled average
                                                                                   data wild-type controls day. average relative activ- functional relatedness highly specific: mutants                 ities mutants days standard deviations shown
lack known component pathway fall                        mutant. relative activity wild-type cells 1.0 pathwayâ€? class (Fig. 1B).                                                          definition.
 1884     KRAUSE ET AL.                                                                                                    EUKARYOT. CELL


way indicate feedback extensive previously recognized.
   interacting genes encode activators CWI signaling. remaining genes PKC1 network encode
activators CWI signaling. Mutants lacking proteins low pathway activity, rendering hypersensi-
tive reduction. total, mutants displayed low
basal Rlm-LacZ reporter activity, consistent compro-
mised CWI signaling: bck1âŒ¬, egd1âŒ¬, ctf19âŒ¬, ydl203câŒ¬ (Fig.
2). BCK1 encodes known MAP kinase kinase kinase absolutely required activity Slt2 Rlm1. Rlm1-LacZ
                                                                      FIG. 3. Ydl203c/Ack1 activates Rlm1-LacZ reporter activity reporter activity minimal mutant (â¬?2  wild-type
                                                                    required stress induction reporter.   Wild-type cells
levels). EGD1 encodes subunit nascent polypeptide-         cotransformed Rlm1-LacZ reporter plasmid associated complex (30). CTF19, gene regulated CWI         vector control plasmid expressing YDL203c GAL1,10
pathway (31), encodes protein involved accurate mitotic        promoter. transformed cells grown synthetic medium
chromosome segregation (13). egd1âŒ¬ ctf19âŒ¬ mutants          containing galactose sucrose induce expression YDL203c.
                                                                    transformed cells assayed â?¤-galactosidase activity. display modest reductions reporter activity (â¬ƒ81             experiment performed triplicate. relative activity 
â¬ƒ66  wild-type levels, respectively). Egd1 Ctf19         termined relative average activity vector controls analyzed novel activators CWI signaling, roles remain     day. Standard deviations replicates shown clarified. Finally, mutants lacking uncharacterized          strain. (B) Wild-type yld203câŒ¬ cells transformed                                                                     Rlm1-LacZ reporter construct examined ability acti-
YDL203c gene display substantial reductions reporter gene
                                                                    vate expression reporter construct. Overnight cell cultures
activity  â¬ƒ25  wild-type levels).                        diluted treated 150 â?®g/ml calcofluor white
   Ydl203c/Ack1 novel upstream activator Pkc1. Loss      (CW), 200 â?®g/ml chlorpromazine (CPZ), 40 â?®g/ml latrunculin B
YDL203c results low Rlm1-LacZ reporter activity. stau-       (LatB) 3 hours prior assay â?¤-galactosidase activity. rosporine hypersensitivity ydl203câŒ¬ suppressed sorbi-      activity determined relative untreated, wild-type cells,
                                                                    analyses performed triplicate day. Stan-
tol, supporting role Ydl203c CWI/Pkc1 pathway          dard deviations replicates shown strain.
(Fig. 1B data shown). Ydl203c important CWI signaling, mutants lacking protein display appropriate phenotype. mutants tem-
perature sensitive growth hypersensitive tunica-     (Fig. 4A B). Second, examined overexpression mycin treatment (Table 2 data shown).                       YDL203c suppress defects mutants defective    Ydl203c bona fide regulator CWI signaling,    various levels pathway. overexpression expect overproduction activation stimulate reporter       gene efficiently suppresses defects rom2âŒ¬ tus1âŒ¬
activity.  overexpression YDL203c         mutants wsc1âŒ¬/wsc1âŒ¬ mutants lacking major upstream
wild-type cells elevates Rlm1-LacZ reporter activity approx-     sensor defects pkc1ts slt2âŒ¬/slt2âŒ¬ mutants
imately twofold (Fig. 3A).                                          lacking key downstream components. data point    activation CWI signaling compromised ydl203câŒ¬         possibility Ydl203c acts Pkc1 pathway mutant? assayed activation reporter activity wild-type     upstream Pkc1 (Fig. 4C D). rename gene ACK1 ydl203câŒ¬ mutants cell surface stresses (calcofluor         (activator C kinase 1).
white chlorpromazine treatment) actin depolymer-            clear molecular mode action indicated se-
ization (latrunculin B treatment). reporter     quence Ack1 save presence SEL-1 domain,
efficiently activated mutant treat-     suggesting possibility protein-protein interactions (24).
ments tested (Fig. 3B). Ydl203c required       recent proteomic studies link Ack1 Rho1 GEFs: transduction cell surface actin cytoskeleton defects   Ack1 complexes Rom2 (8, 9) Tus1 (8), CWI pathway. Activation reporter activity           consistent role upstream Pkc1 CWI pathway.
latrunculin B treatment   efficient          Does Ack1 act Rho1 GEFs? genetic analysis treatment cell surface stressors, indicating     indicates Rom2 activity wholly dependent Ack1
Ydl203c preferentially enhance input. Overall,         vice versa: overexpression suppresses defect
protein appears selectively affect CWI sig-        caused absence  holds Tus1
naling basal induced conditions.                     Ack1. possible explanations.  Ack1
   Ydl203c acts Pkc1 pathway, epistatic       act independently main Rho1 GEFs stimu-
analysis specify point action protein.       late Pkc1 activity. Second, Ack1 act Rho1 GEFs,
undertook complementary analyses.  examined         activity wholly dependent Ack1. activation overexpression known pathway components,           model applies, ACK1 affect CWI sig-
ranging upstream Rom2 Tus1 Rho1 GEFs            naling absence Rom2 Tus1; downstream Slt2 MAP kinase, suppress tunicamycin          applies, ACK1 function abolished absence
sensitivity ydl203câŒ¬ mutants. activation        Rho1 GEFs. constructed rom2âŒ¬ tus1âŒ¬ double
overexpression corresponding genes efficiently       mutant haploids standard genetic manipulations. suppress mutant defect, consistent idea           double mutant viable strain background Ydl203c acts upstream Rho1 GEFs pathway         temperature sensitive hypersensitive benomyl.  VOL. 7, 2008                                                                                GENETIC NETWORK PKC1                      1885


                                                                                                       âˆ†
                                                                    âˆ†
                                     Âµ
                                     Âµ
                                     Âµ
                                     Âµ
                                     Âµ

                                                                                                âˆ†
                                                                                                           âˆ†

                                 âˆ†
                                 âˆ†
                                âˆ†
                                                                                                           âˆ†
                               âˆ†âˆ†
                                âˆ†      âˆ†                                                        âˆ†
                                âˆ†      âˆ†
   FIG. 4. Epistasis analysis places Ydl203c/Ack1 Pkc1 pathway upstream Pkc1.   ydl203câŒ¬ cells transformed plasmids
overexpressing ROM2, TUS1, PKC1, MKK1, SLT2 vector control. Transformed cells grown synthetic medium, diluted OD600 0.02, serially diluted fresh medium. dilutions spotted synthetic medium plates containing tunicamycin (Tm; 1.5
â?®g/ml). plates incubated 25Â°C 2 days, growth transformants compared vector control. â€œâ«¹â€? indicates
growth better vector control. (B) Example suppression tunicamycin hypersensitivity ydl203câŒ¬ cells overexpression ROM2. (C) wsc1âŒ¬/wsc1âŒ¬, rom2âŒ¬, tus1âŒ¬, pkc1ts, slt2âŒ¬/âŒ¬, rom2âŒ¬ tus1âŒ¬ cells congenic wild-type cells transformed vector
control plasmid expressing YDL203c GAL1,10 promoter. transformed cells streaked synthetic medium plates
containing galactose sucrose induce expression YDL203c. Plates incubated 25Â°C, duplicate set incubated 37Â°C examine ability Ydl203c suppress temperature sensitivity pkc1ts, slt2âŒ¬/âŒ¬, rom2âŒ¬ tus1âŒ¬ cells. Plates containing benomyl (20
â?®g/ml) used assess ability YDL203c overexpression suppress benomyl hypersensitivity rom2âŒ¬ rom2âŒ¬ tus1âŒ¬ cells. Plates
containing chlorpromazine (200 â?®g/ml) used examine ability YDL203c overexpression suppress chlorpromazine hypersen-
sitivity tus1âŒ¬ cells. Plates containing calcofluor white (25 â?®g/ml) used examine ability YDL203c overexpression suppress calcofluor white hypersensitivity wsc1âŒ¬/wsc1âŒ¬ cells. plates incubated 25Â°C 2 days growth transformants assessed. â€œâ«¹â€? indicates growth better vector control transformants; â€œâ«ºâ€? indicates growth equal vector control.
(D) Example ability YDL203c overexpression suppress benomyl hypersensitivity rom2âŒ¬ cells. Wt, wild type.


 overexpression ACK1 unable suppress             genetic analysis useful addition genetic defects tested rom2âŒ¬ tus1âŒ¬ double mutants (Fig. 4              arsenal.
data shown). role, Ack1 novel upstream                  genetic interaction network PKC1. synthetic
activator CWI-Pkc1 signaling functionally dependent              lethal network PKC1 rich genes functionally Rho1 GEFs.                                                             closely linked Pkc1. 21 null mutants display                                                                            appropriate chemical sensitivities (Table 2). independent
                          DISCUSSION                                       chemical-genetic epistasis test places thirds genes
                                                                           functional envelope Pkc1 (Fig. 1),    DN-SGA analysis.  report adaptation SGA                   encode known components CWI pathway. confirm
methodology, DN-SGA, â€œqueryâ€? mutation dom-                    gene, YDL203c/ACK1, encodes novel modula-
inant negative expressed trans plasmid              tor pathway  . findings consistent control regulatable promoter. case PKC1
                                                                           long-held expectation genetic enhancements hypo-
query, adapted method identified true positives high
                                                                           morphic alleles efficiently enrich mutations affecting degree specificity: â¬Ž95  primary strains identified                                                                            pathway biological process (26).
robustly sensitive expression dominant-negative allele
                                                                              synthetic lethal network PKC1 preferentially sensitive protein kinase C inhibitor
                                                                           identifies components CWI pathway, staurosporine.
                                                                           known components pathway represented    DN-SGA analysis strengths. query al-
lele plasmid borne extrachromosomal,                network? multiple possible reasons.  genetically linked chromosomal locus (16). entire               components, like Rho1, essential covered genome surveyed approach. Second,                   analysis. Second, components redundant, e.g., Mkk1
lethality dependent conditional expression                Mkk2, mutation gene causes little dominant-negative query allele, terminal phenotype asso-               phenotypic change.  components 
ciated synthetic lethal interaction easily             volved branches processes contribute termined. example, synthetic lethal interac-               essential role(s) Pkc1. Fourth, components tions PKC1 reported accompanied increased                 contribute preferentially activated cell lysis, consistent idea cell integrity defect          basal state pathway. mutations affecting basal
underlies majority interactions (S.  Krause             activity identified nonstressed conditions
J. V. Gray, unpublished observations). DN-SGA analysis ex-                 examined  Finally, SGA analysis 
tends range alleles amenable systematic                 rivatives systematic genome-wide, suffer high
 1886     KRAUSE ET AL.                                                                                                             EUKARYOT. CELL


rate false negatives (36). genetic screens              Ack1 new upstream component Pkc1 pathway.
fully saturating.                                                    Multiple lines evidence place uncharacterized protein
   Functional relationships underlying genetic network.          Ydl203c/Ack1 Pkc1 pathway.  ack1âŒ¬ mutants  probed likely functional relationships        hypersensitive lowered Pkc1 activity. Second, hypersen-
underlie genetic interactions PKC1. estimated            sitivity efficiently suppressed osmotic stabilization (Fig. 1),
Pkc1 pathway activity mutant using Rlm1-LacZ           placing Ack1 function envelope Pkc1 vivo
reporter, faithful indicator Pkc1-Slt2 activity state (17).     activity.  CWI pathway compromised ack1âŒ¬ identified distinct subgroups            mutants: mutants display low Rlm1-LacZ reporter activity
PKC1 network. consider turn.                              (Fig. 2) hypersensitive tunicamycin (Table 2),    majority (12/21) mutants PKC1         hypersensitivity suppressed overexpression network display high basal reporter activity, consistent    pathway components (Fig. 4A). Fourth, overexpression idea mutants cause defects Pkc1 path-         ACK1 sufficient stimulate CWI pathway activity: overex-
way responds. mutants particularly dependent          pression sufficient suppress defects mutants Pkc1 activity high activity required ameliorate   defective upstream signaling (Fig. 4C) elevate basal phenotypic consequences mutations. behavior          Rlm1-LacZ reporter activity (Fig. 3A). Finally, standard ep- expected signaling pathways affect cell viability    istasis analysis places Ack1 pathway indicates negative-feedback control. conditions ap-        acts upstream Pkc1 (Fig. 4).
ply Pkc1/CWI pathway: overall pathway essential           fully understand Ack1 modulates CWI known feedback control activity state      signaling. protein complex nonessential, downstream MAP kinase module (22).              Rho1 GEFs Rom2 (8, 9) Tus1 (8).  genetic data point possibility feedback control      analysis indicates Rom2 Tus1 required extensive embraces Bni1 Mig1 branches.              Ack1 affect CWI signaling: overexpression ACK1    mutants display normal basal reporter activity,        suppress defects rom2âŒ¬ tus1âŒ¬ mutants suggestive normal Pkc1 pathway activity, assessed       double mutant (Fig. 4C). Ack1 modulator
activity Slt2-Rlm1-dependent reporter. mutants            scaffold Rho1 GEF complexes. role, deficient branch pathway       does appear grossly alter stability proteins MAP kinase branch controls Rlm1-LacZ reporter.           subcellular localization (S.  Krause J. V. Gray,
addition, CWI pathway activity  assessed reporter          unpublished observations). investigations ongoing.
gene activity) feedback control response           Ack1 clearly important setting activity level loss gene products: activity remains normal. Alter-      pathway does appear required gross activation
natively, mutants deficient process          pathway response cell surface cytoskeletal 
pathway acts parallel CWI pathway           fects (Fig. 3B). mode action, Ack1 joins absence surveyed pathway. Examples            increasing number components, including PUF protein types appear represented mutant class:        Mpt5 (34) ubiquitination enzyme Ubp3 (39), point
chemical-genetic epistasis test (Fig. 1) places     unanticipated complexity setting modulating pathway
proteins envelope Pkc1 function.      activity.
known components pathway: Spa2 Mid1. Spa2                                                                                                ACKNOWLEDGMENTS
important proper localization Slt2 MAP kinase, localization important activation Rlm1          thank David Levin, David Pellman, Mike Hall plasmids;
transcription factor Slt2. Mid1 putative calcium channel     Charlie Boone query strains; Josephine McGhie technical
                                                                     support. thank laboratory members colleagues helpful
lying separate branch relative MAP kinase module,
                                                                     discussions.
leaving Slt2-Rlm1 communication fully intact.                          work supported research grants C20144 BB/
   Finally, null mutants display compromised reporter ac-       E011632 Biotechnology Biological Sciences Research
tivity, suggestive low Pkc1-Slt2-Rlm1 activity. mutants      Council (J.V.G.). hypersensitive reduction Pkc1 activity                                         REFERENCES activity Pkc1  assessed Slt2-Rlm1-dependent           1. Baetz, K., J. Moffat, J. Haynes, M. Chang, B. Andrews. 2001. Transcrip-
reporter) unstressed mutants closer minimal thresh-         tional coregulation cell integrity mitogen-activated protein kinase Slt2
                                                                         cell cycle regulator Swi4. Mol. Cell. Biol. 21:6515â€“6528.
old activity kinase required support cell viability.        2. Benachour, , G. Sipos,  Flury, F. Reggiori, E. Canivenc-Gansel, C. Vion- mutants lack positively acting components            net,  Conzelmann, M. Benghezal. 1999. Deletion GPI7, yeast gene
pathway.  genes behave chemical-genetic             required addition chain glycosylphosphatidylinositol
                                                                         (GPI) core structure, affects GPI protein transport, remodeling, cell wall
epistasis test Pkc1 pathway (Fig. 1). mutant          integrity. J. Biol. Chem. 274:15251â€“15261. lowest reporter activity lacks Bck1, kinase known       3. Bidlingmaier, S., M. Snyder. 2002. Large-scale identification genes required communication Pkc1 Slt2.                  important apical growth Saccharomyces cerevisiae directed allele
                                                                         replacement technology (DART) screening. Funct. Integr. Genomics 1:345â€“
contrast, mutants lacking EGD1 CTF19 display                  356.
modest reporter defect. relationships Edg1            4. Choi, M. G., V. Kurnov, M. C. Kersting,  Sreenivas, G. M. Carman.
                                                                         2005. Phosphorylation yeast choline kinase protein kinase C.
Ctf19 CWI signaling established,             Identification Ser25 Ser30 major sites phosphorylation. J. Biol.
CTF19 transcriptional target pathway (31).               Chem. 280:26105â€“26112.
fourth mutant, lacking YDL203c/ACK1, displays interme-             5. Filippi, L., M. Fournier, E. Cameroni, P. Linder, C. DeVirgilio, M. Foti,
                                                                         O. Deloche. 2007. Membrane stress coupled rapid translational
diate reporter defect. gene encodes           control gene expression chlorpromazine-treated cells. Curr. Genet.
novel activator CWI signaling  .                            52:171â€“185.
 VOL. 7, 2008                                                                                              GENETIC NETWORK PKC1                                1887

 6. Evangelista, M., S. Zigmond, C. Boone. 2003. Formins: signaling effec-        26. Ooi, S. L., X. Pan, B. D. Peyser, P. Ye, P. B. Meluh, D. S. Yuan, R.  Irizarry,
    tors assembly polarization actin filaments. J. Cell Sci. 116:2603â€“         J. S. Bader, F.  Spencer, J. D. Boeke. 2006. Global synthetic-lethality
    2611.                                                                                 analysis yeast functional profiling. Trends Genet. 22:56â€“66.
 7. Fujita, M., M. Umemura, T. Yoko-o, Y. Jigami. 2006. PER1 required          27. Pan, X., D. S. Yuan, D. Xiang, X. Wang, S. Sookhai-Mahadeo, J. S. Bader,
    GPI-phospholipase A2 activity involved lipid remodeling GPI-            P. Heiter, F. Spencer, J. D. Boeke. 2004. robust toolkit functional
    anchored proteins. Mol. Biol. Cell 17:5253â€“5264.                                      profiling yeast genome. Mol. Cell 16:487â€“496.
 8. Gavin,  C., M. Bosche, R. Krause, P. Grandi, M. Marzioch. 2002.             28. Philip, B., D. E. Levin. 2001. Wsc1 Mid2 cell surface sensors     Functional organization yeast proteome systematic analysis               cell wall integrity signaling act Rom2, guanine nucleotide
    protein complexes. Nature 415:141â€“147.                                                exchange factor Rho1. Mol. Cell. Biol. 21:271â€“280.
 9. Gavin,  C., P. Aloy, P. Grandi, R. Krause, M. Boesche, M. Marzioch, C.          29. Pringle, J. R. 1991. Staining bud scars cell wall chitin     Rau, L. J. Jensen, S. Bastuck, B. Dumpelfeld,  Edelmann, M.  Heurtier,            calcofluor. Methods Enzymol. 194:732â€“735.
    V. Hoffman, C. Hoefert, K. Klein, M. Hudak,  M. Michon, M. Schelder, M.         30. Reimann, B., J. Bradsher, J. Franke, E. Hartmann, M. Wiedmann, S. Prehn,
    Schirle, M. Remor, T. Rudi, S. Hooper,  Bauer, T. Bouwmeester, G.                   B. Wiedmann. 1999. Initial characterization nascent polypeptide-
    Casari, G. Drewes, G. Neubauer, J. M. Rick, B. Kuster, P. Bork, R. B.                 associated complex yeast. Yeast 15:397â€“407.
    Russell, G. Superti-Furga. 2006. Proteome survey reveals modularity        31. Roberts, C. J., B. Nelson, M. J. Marton, R. Stoughton, M. R. Meyer, H. 
    yeast cell machinery. Nature 440:631â€“636.                                         Bennett, Y. D.  H. Dai, W. L. Walker, T. R. Hughes, M. Tyers, C. Boone,
10. Gietz, R. D., R. H. Scheistl,  R. Wellems, R.  Woods. 1995. Studies           S. H. Friend. 2000. Signaling circuitry multiple MAPK pathways
    transformation intact yeast cells LiAc/SS-DNA/PEG pro-               revealed matrix global gene expression profiles. Science 287:873â€“880.
    cedure. Yeast 11:355â€“360.                                                         32. Schmelzle, T., S. B. Helliwell, M. N. Hall. 2002. Yeast protein kinases
11. Gray, J. V., J. P. Ogas, Y. Kamada, M. Stone, D. E. Levin,  Herskowitz.         Rho1 exchange factor Tus1 novel components cell integ-
    1997. role Pkc1 MAP kinase pathway Saccharyomces cerevisiae              rity pathway yeast. Mol. Cell. Biol. 22:1329â€“1339.
    bud emergence identification putative upstream regulator.             33. Schmidt, , M. Bickle, T. Beck, M. N. Hall. 1997. yeast phospha-
    EMBO J. 16:4924â€“4937.                                                                 tidylinositol kinase homolog Tor2 activates Rho1 Rho2 exchange
12. Harrison, J. C., E. S. Bardes, Y. Ohya, D. J. Lew. 2001. role           factor Rom2. Cell 88:531â€“542.
    Pkc1p/Mpk1p kinase cascade morphogenesis checkpoint. Nat. Cell
                                                                                      34. Stewart, M. S., S.  Krause, J. McGhie, J. V. Gray. 2007. Mpt5p, stress
    Biol. 3:417â€“420.
                                                                                          tolerance- lifespan-promoting PUF protein Saccharomyces cerevisiae,
13. Hyland, K. M., J. Kingsbury, D. Koshland, P. Hieter. 1999. Ctf19p:                                                                                           acts upstream cell wall integrity pathway. Eukaryot. Cell 6:262â€“270.
    novel kinetochore protein Saccharomyces cerevisiae potential link
                                                                                      35. Tamaoki, T., H. Nomoto,  Takahashi, Y. Kato, M. Morimoto, F.
    kinetochore mitotic spindle. J. Cell Biol. 145:15â€“28.
                                                                                          Tomita. 1986. Staurosporine, potent inhibitor phospholipid/Ca2â«¹ 
14. Irie, K., M. Takase, S. Leek, D. E. Levin, H. Araki, K. Matsumoto, Y.
                                                                                          pendent protein kinase. Biochem. Biophys. Res. Commun. 135:397â€“4